Alex Tancredi

Alex Tancredi is a seasoned professional with extensive experience in strategic roles across various companies in the biotechnology and investment sectors. Currently serving as Principal at Hastings Equity Partners, LLC, Alex has previously held positions as VP at Curie.Bio and VP, Head of Strategy and Business Development at Octant. Alex's career also includes significant roles at Relay Therapeutics, where responsibilities encompassed Director of Corporate Development and Strategy and Associate Director of Business Development. Earlier experience includes a position as a Private Equity Investor, Associate at Charlesbank Capital Partners. Alex holds a BA in Neuroscience/Psychology from Harvard University and an MBA from Stanford University Graduate School of Business.